Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

Top 2 Defensive Stocks Which Could Rescue Your Portfolio In March

By Avi Kapoor

March 28, 7:35 AM

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

ISPR

Nerdy Q2 Sales $42.20M Beat $38.47M Estimate

By Benzinga Newsdesk

August 15, 4:12 PM

Nerdy (NYSE:NRDY) reported quarterly sales of $42.20 million which beat the analyst consensus estimate of $38.47 million by 9.70 percent.

NRDY

Why VectivBio Shares Are Surging Monday

By Adam Eckert

May 22, 10:12 AM

VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) agreed to

IRWD

News

Blink Charging Provides More Than 4,000 Automotive Dealerships Globally With EV Charging Products And Solutions To Support Soaring Consumer Demand For Electric Vehicles

By Benzinga Newsdesk

July 20, 9:13 AM

Over 8,400 chargers have been deployed to dealerships globally to meet infrastructure requirements for rapidly growing EV sales.Miami Beach, Fla., July 20, 2023 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ:BLNK)

BLNK

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Related Posts

Top 2 Defensive Stocks Which Could Rescue Your Portfolio In March

Nerdy Q2 Sales $42.20M Beat $38.47M Estimate

Why VectivBio Shares Are Surging Monday

Blink Charging Provides More Than 4,000 Automotive Dealerships Globally With EV Charging Products And Solutions To Support Soaring Consumer Demand For Electric Vehicles